BFRIW
Biofrontera Inc.
Price Chart
Latest Quote
$0.02
-0.01 (-22.95%)
Current Price
| Previous Close | $0.03 |
| Open | $0.10 |
| Day High | $0.03 |
| Day Low | $0.02 |
| Volume | 1,460 |
Stock Information
| Total Debt | $7.72M |
| Cash Equivalents | $6.33M |
| Revenue | $43.20M |
| Net Income | $-11.09M |
| EPS (TTM) | $-1.30 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $43.20M |
| Income | $-11.09M |
| Book/sh | $0.52 |
| Employees | 84 |
Financial Ratios
| Quick Ratio | 0.99 |
| Current Ratio | 1.21 |
| Debt/Eq | 127.25 |
Returns & Margins
| ROA | -32.41% |
| ROE | -339.04% |
| Gross Margin | 77.29% |
| Operating Margin | -38.95% |
| Profit Margin | -25.66% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.04 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| RSI | nan |
| ATR | nan |
| Shares Float | 8.06M |
| Volatility | 0.85 |
| Rel Volume | 20.00 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| YTD | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $nan | 1,460 |
| 2026-06-12 | $0.06 | 0 |
| 2026-06-11 | $0.06 | 0 |
| 2026-06-10 | $0.06 | 0 |
| 2026-06-09 | $0.06 | 0 |
| 2026-06-08 | $0.06 | 0 |
| 2026-06-05 | $0.06 | 0 |
| 2026-06-04 | $0.06 | 0 |
| 2026-06-03 | $0.06 | 0 |
| 2026-06-02 | $0.06 | 0 |
| 2026-06-01 | $0.06 | 0 |
| 2026-05-29 | $0.06 | 0 |
| 2026-05-28 | $0.06 | 0 |
| 2026-05-27 | $0.06 | 0 |
| 2026-05-26 | $0.06 | 0 |
| 2026-05-22 | $0.06 | 0 |
| 2026-05-21 | $0.06 | 0 |
| 2026-05-20 | $0.06 | 0 |
| 2026-05-19 | $0.06 | 0 |
| 2026-05-18 | $0.06 | 0 |
About Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
đ° Latest News
Biofrontera (BFRI) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-06-02T17:16:02Z
Biofrontera Inc (BFRI) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-05-14T23:04:28ZBiofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-14T13:25:02Z
Biofrontera Inc (BFRI) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-03-21T01:01:46ZBiofrontera (BFRI) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-03-19T15:17:49Z
Biofrontera Inc. close purchase of all Ameluz, RhodoLED U.S. assets
TipRanks âĸ 2025-10-24T12:55:43Z
Biofrontera Inc. (NASDAQ:BFRI): When Will It Breakeven?
Simply Wall St. âĸ 2025-09-28T14:17:14Z
Biofrontera Inc (BFRI) Q2 2025 Earnings Call Highlights: Record Revenue Growth Amid Operational ...
GuruFocus.com âĸ 2025-08-15T07:20:07Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $10,964,000 | $18,607,000 | $17,444,000 | $15,185,000 |
| Cost Of Revenue | $10,964,000 | $18,607,000 | $17,444,000 | $15,185,000 |
| Total Revenue | $41,705,000 | $37,321,000 | $34,071,000 | $28,674,000 |
| Operating Revenue | $41,705,000 | $37,321,000 | $34,071,000 | $28,674,000 |
| Expenses | ||||
| Interest Expense | $452,000 | $2,035,000 | $600,000 | $370,000 |
| Total Expenses | $53,053,000 | $54,531,000 | $56,648,000 | $51,055,000 |
| Other Income Expense | $1,289,000 | $1,508,000 | $3,020,000 | $21,976,000 |
| Other Non Operating Income Expenses | $388,000 | $158,000 | $-3,000 | $69,000 |
| Net Non Operating Interest Income Expense | $-452,000 | $-2,035,000 | $-560,000 | $-203,000 |
| Interest Expense Non Operating | $452,000 | $2,035,000 | $600,000 | $370,000 |
| Operating Expense | $42,089,000 | $35,924,000 | $39,204,000 | $35,870,000 |
| Total Other Finance Cost | - | $41,000 | $92,000 | $8,000 |
| General And Administrative Expense | - | - | $39,127,000 | $35,870,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Net Interest Income | $-452,000 | $-2,035,000 | $-560,000 | $-203,000 |
| Normalized Income | $-11,247,790 | $-18,825,500 | $-22,519,170 | $-17,946,530 |
| Net Income From Continuing And Discontinued Operation | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Total Operating Income As Reported | $-11,348,000 | $-17,210,000 | $-22,677,000 | $-18,581,000 |
| Net Income Common Stockholders | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Net Income | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Net Income Including Noncontrolling Interests | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Net Income Continuous Operations | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Pretax Income | $-10,511,000 | $-17,737,000 | $-20,117,000 | $-608,000 |
| Special Income Charges | $0 | $-316,000 | $7,419,000 | $3,800,000 |
| Operating Income | $-11,348,000 | $-17,210,000 | $-22,577,000 | $-22,381,000 |
| Gross Profit | $30,741,000 | $18,714,000 | $16,627,000 | $13,489,000 |
| Interest Income | - | $71,000 | $132,000 | $175,000 |
| Interest Income Non Operating | - | $71,000 | $132,000 | $175,000 |
| Other | ||||
| Tax Effect Of Unusual Items | $189,210 | $283,500 | $634,830 | $4,600,470 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-10,092,000 | $-15,903,000 | $-21,476,000 | $-20,973,000 |
| Total Unusual Items | $901,000 | $1,350,000 | $3,023,000 | $21,907,000 |
| Total Unusual Items Excluding Goodwill | $901,000 | $1,350,000 | $3,023,000 | $21,907,000 |
| Reconciled Depreciation | $868,000 | $1,149,000 | $1,064,000 | $1,172,000 |
| EBITDA (Bullshit earnings) | $-9,191,000 | $-14,553,000 | $-18,453,000 | $934,000 |
| EBIT | $-10,059,000 | $-15,702,000 | $-19,517,000 | $-238,000 |
| Diluted NI Availto Com Stockholders | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Tax Provision | $25,000 | $22,000 | $14,000 | $32,000 |
| Gain On Sale Of Security | $901,000 | $1,666,000 | $-4,396,000 | $18,107,000 |
| Research And Development | $3,719,000 | $2,089,000 | $77,000 | $0 |
| Selling General And Administration | $38,370,000 | $33,835,000 | $39,127,000 | $35,870,000 |
| Other Special Charges | - | $316,000 | $-7,519,000 | - |
| Restructuring And Mergern Acquisition | - | $0 | $100,000 | $-3,800,000 |
| Other Gand A | - | - | $39,127,000 | $35,870,000 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $7,830,000 | $4,398,000 | $2,164,000 | $20,846,000 |
| Total Assets | $28,564,000 | $22,101,000 | $27,932,000 | $50,884,000 |
| Total Non Current Assets | $10,481,000 | $1,401,000 | $4,857,000 | $7,744,000 |
| Other Non Current Assets | $4,089,000 | $383,000 | $482,000 | $320,000 |
| Goodwill And Other Intangible Assets | $2,650,000 | $35,000 | $2,629,000 | $3,032,000 |
| Other Intangible Assets | $2,650,000 | $35,000 | $2,629,000 | $3,032,000 |
| Current Assets | $18,083,000 | $20,700,000 | $23,075,000 | $43,140,000 |
| Other Current Assets | $1,193,000 | $243,000 | $5,584,000 | $286,000 |
| Assets Held For Sale Current | $0 | $2,300,000 | $0 | - |
| Prepaid Assets | $554,000 | $227,000 | $305,000 | $524,000 |
| Inventory | $1,426,000 | $6,646,000 | $10,908,000 | $7,168,000 |
| Receivables | $8,509,000 | $5,372,000 | $5,162,000 | $7,406,000 |
| Taxes Receivable | $1,218,000 | $57,000 | - | - |
| Accounts Receivable | $7,291,000 | $5,315,000 | $5,162,000 | $3,748,000 |
| Allowance For Doubtful Accounts Receivable | $-100,000 | $-200,000 | $-200,000 | $-100,000 |
| Gross Accounts Receivable | $7,391,000 | $5,515,000 | $5,362,000 | $3,848,000 |
| Cash Cash Equivalents And Short Term Investments | $6,401,000 | $5,912,000 | $1,421,000 | $27,756,000 |
| Cash And Cash Equivalents | $6,392,000 | $5,905,000 | $1,343,000 | $17,208,000 |
| Non Current Accounts Receivable | - | - | - | $2,813,000 |
| Other Receivables | - | - | - | - |
| Debt | ||||
| Total Debt | $6,161,000 | $4,922,000 | $5,399,000 | $1,346,000 |
| Long Term Debt And Capital Lease Obligation | $5,829,000 | $4,374,000 | $804,000 | $848,000 |
| Long Term Debt | $4,589,000 | $4,098,000 | - | - |
| Current Debt And Capital Lease Obligation | $332,000 | $548,000 | $4,595,000 | $498,000 |
| Net Debt | - | - | $2,561,000 | - |
| Current Debt | - | - | $3,904,000 | - |
| Other Current Borrowings | - | - | $3,904,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $18,084,000 | $17,668,000 | $23,139,000 | $27,006,000 |
| Total Non Current Liabilities Net Minority Interest | $6,189,000 | $5,647,000 | $5,051,000 | $6,112,000 |
| Other Non Current Liabilities | $9,000 | $23,000 | $37,000 | $21,000 |
| Derivative Product Liabilities | $351,000 | $1,250,000 | $4,210,000 | $2,843,000 |
| Current Liabilities | $11,895,000 | $12,021,000 | $18,088,000 | $20,894,000 |
| Other Current Liabilities | $320,000 | $613,000 | $686,000 | $372,000 |
| Payables And Accrued Expenses | $8,381,000 | $8,374,000 | $10,473,000 | $10,150,000 |
| Payables | $6,666,000 | $7,200,000 | $9,006,000 | $2,590,000 |
| Accounts Payable | $1,855,000 | $1,856,000 | $3,308,000 | $1,278,000 |
| Non Current Deferred Liabilities | - | - | $0 | $2,400,000 |
| Current Deferred Liabilities | - | - | $0 | $6,942,000 |
| Equity | ||||
| Common Stock Equity | $10,480,000 | $4,433,000 | $4,793,000 | $23,878,000 |
| Total Equity Gross Minority Interest | $10,480,000 | $4,433,000 | $4,793,000 | $23,878,000 |
| Stockholders Equity | $10,480,000 | $4,433,000 | $4,793,000 | $23,878,000 |
| Retained Earnings | $-127,945,000 | $-117,409,000 | $-99,650,000 | $-79,519,000 |
| Other | ||||
| Ordinary Shares Number | $11,648,323 | $8,873,932 | $1,517,628 | $1,334,950 |
| Share Issued | $11,648,323 | $8,873,932 | $1,517,628 | $1,334,950 |
| Tangible Book Value | $7,830,000 | $4,398,000 | $2,164,000 | $20,846,000 |
| Invested Capital | $15,069,000 | $8,531,000 | $8,697,000 | $23,878,000 |
| Working Capital | $6,188,000 | $8,679,000 | $4,987,000 | $22,246,000 |
| Capital Lease Obligations | $1,572,000 | $824,000 | $1,495,000 | $1,346,000 |
| Total Capitalization | $15,069,000 | $8,531,000 | $4,793,000 | $23,878,000 |
| Additional Paid In Capital | $138,413,000 | $121,833,000 | $104,441,000 | $103,396,000 |
| Capital Stock | $12,000 | $9,000 | $2,000 | $1,000 |
| Common Stock | $12,000 | $9,000 | $2,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,240,000 | $276,000 | $804,000 | $848,000 |
| Current Capital Lease Obligation | $332,000 | $548,000 | $691,000 | $498,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,805,000 | $2,428,000 | $2,185,000 | $2,850,000 |
| Current Provisions | $57,000 | $58,000 | $149,000 | $82,000 |
| Current Accrued Expenses | $1,715,000 | $1,174,000 | $1,467,000 | $7,560,000 |
| Dueto Related Parties Current | $4,811,000 | $5,344,000 | $5,698,000 | $1,312,000 |
| Net PPE | $3,742,000 | $983,000 | $1,746,000 | $1,579,000 |
| Accumulated Depreciation | $-267,000 | $-613,000 | $-557,000 | $-507,000 |
| Gross PPE | $4,009,000 | $1,596,000 | $1,746,000 | $2,086,000 |
| Leases | $0 | $368,000 | $368,000 | $368,000 |
| Other Properties | $1,584,000 | $903,000 | $1,746,000 | $1,375,000 |
| Machinery Furniture Equipment | $2,425,000 | $325,000 | $323,000 | $343,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $9,000 | $7,000 | $78,000 | $10,548,000 |
| Non Current Deferred Revenue | - | - | $0 | $2,400,000 |
| Current Deferred Revenue | - | - | $0 | $6,942,000 |
| Duefrom Related Parties Non Current | - | - | $0 | $2,813,000 |
| Duefrom Related Parties Current | - | - | $0 | $3,658,000 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-13,363,000 | $-10,330,000 | $-24,900,000 | $-16,237,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-13,361,000 | $-10,270,000 | $-24,895,000 | $-16,199,000 |
| Cash Flow From Continuing Operating Activities | $-13,361,000 | $-10,270,000 | $-24,895,000 | $-16,199,000 |
| Operating Gains Losses | $-1,601,000 | $-1,350,000 | $4,282,000 | $-16,388,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,000 | $-60,000 | $-5,000 | $-38,000 |
| Investing Cash Flow | $2,998,000 | $-3,000 | $619,000 | $-5,156,000 |
| Cash Flow From Continuing Investing Activities | $2,998,000 | $-3,000 | $619,000 | $-5,156,000 |
| Net Other Investing Changes | $3,000,000 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $10,850,000 | $7,662,000 | $4,507,000 | $9,391,000 |
| Financing Cash Flow | $10,850,000 | $14,835,000 | $8,411,000 | $14,021,000 |
| Cash Flow From Continuing Financing Activities | $10,850,000 | $14,835,000 | $8,411,000 | $14,021,000 |
| Net Preferred Stock Issuance | $10,850,000 | $7,662,000 | $0 | - |
| Preferred Stock Issuance | $10,850,000 | $7,662,000 | $0 | - |
| Net Common Stock Issuance | - | $0 | $4,507,000 | $9,391,000 |
| Common Stock Issuance | - | $0 | $4,507,000 | $9,391,000 |
| Other | ||||
| Repayment Of Debt | $0 | $-4,315,000 | $-21,344,000 | - |
| Interest Paid Supplemental Data | $6,000 | $1,728,000 | $147,000 | $1,000 |
| Income Tax Paid Supplemental Data | $25,000 | $24,000 | $15,000 | $32,000 |
| End Cash Position | $6,592,000 | $6,105,000 | $1,543,000 | $17,408,000 |
| Beginning Cash Position | $6,105,000 | $1,543,000 | $17,408,000 | $24,742,000 |
| Changes In Cash | $487,000 | $4,562,000 | $-15,865,000 | $-7,334,000 |
| Proceeds From Stock Option Exercised | $0 | $7,438,000 | $0 | $4,630,000 |
| Net Issuance Payments Of Debt | $0 | $-265,000 | $3,904,000 | $0 |
| Net Short Term Debt Issuance | $0 | $-265,000 | $3,904,000 | $0 |
| Short Term Debt Payments | $0 | $-4,315,000 | $-21,344,000 | - |
| Net Investment Purchase And Sale | $0 | $57,000 | $624,000 | $-5,118,000 |
| Sale Of Investment | $0 | $57,000 | $624,000 | $0 |
| Net Intangibles Purchase And Sale | $0 | $-50,000 | $0 | - |
| Purchase Of Intangibles | $0 | $-50,000 | $0 | - |
| Net PPE Purchase And Sale | $-2,000 | $-10,000 | $-5,000 | $-38,000 |
| Purchase Of PPE | $-2,000 | $-10,000 | $-5,000 | $-38,000 |
| Change In Working Capital | $-3,484,000 | $6,212,000 | $-4,394,000 | $2,788,000 |
| Change In Other Current Liabilities | $-683,000 | $-689,000 | $-657,000 | $-781,000 |
| Change In Other Current Assets | $-686,000 | $5,159,000 | $-5,159,000 | $0 |
| Change In Payables And Accrued Expense | $75,000 | $-2,037,000 | $64,000 | $-2,695,000 |
| Change In Accrued Expense | $610,000 | $-230,000 | $-6,351,000 | $-3,607,000 |
| Change In Payable | $-535,000 | $-1,807,000 | $6,415,000 | $912,000 |
| Change In Account Payable | $-535,000 | $-1,807,000 | $6,415,000 | - |
| Change In Prepaid Assets | $-1,728,000 | $-141,000 | $174,000 | $4,154,000 |
| Change In Inventory | $1,445,000 | $4,233,000 | $-3,750,000 | $-2,810,000 |
| Change In Receivables | $-1,907,000 | $-313,000 | $4,934,000 | $4,920,000 |
| Changes In Account Receivables | $-1,907,000 | $-315,000 | $-1,536,000 | $-70,000 |
| Other Non Cash Items | $510,000 | $297,000 | $-6,883,000 | $-3,442,000 |
| Stock Based Compensation | $951,000 | $1,019,000 | $1,045,000 | $1,852,000 |
| Provisionand Write Offof Assets | $-69,000 | $162,000 | $122,000 | $206,000 |
| Depreciation Amortization Depletion | $868,000 | $1,149,000 | $1,064,000 | $1,172,000 |
| Depreciation And Amortization | $868,000 | $1,149,000 | $1,064,000 | $1,172,000 |
| Depreciation | $868,000 | $1,149,000 | $646,000 | $754,000 |
| Gain Loss On Investment Securities | $-901,000 | $-1,666,000 | $4,282,000 | $-16,388,000 |
| Gain Loss On Sale Of PPE | $-700,000 | $0 | - | - |
| Net Income From Continuing Operations | $-10,536,000 | $-17,759,000 | $-20,131,000 | $-640,000 |
| Issuance Of Debt | - | $4,050,000 | $25,248,000 | $0 |
| Short Term Debt Issuance | - | $4,050,000 | $25,248,000 | $0 |
| Amortization Cash Flow | - | $329,000 | $418,000 | $418,000 |
| Amortization Of Intangibles | - | $329,000 | $418,000 | $418,000 |
| Net Long Term Debt Issuance | - | - | $21,448,000 | $0 |
| Long Term Debt Issuance | - | - | $21,448,000 | $0 |
| Purchase Of Investment | - | - | $0 | $-5,118,000 |
| Unrealized Gain Loss On Investment Securities | - | - | $7,421,000 | $-1,747,000 |
Fetched: 2026-06-14